مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

248
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

143
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

HALF‑DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Pages

  66-69

Abstract

 Purpose: To report the outcomes of half‑dose PHOTODYNAMIC THERAPY (PDT) in patients with chronic CENTRAL SEROUS CHORIORETINOPATHY (CSC).Methods: A chart review of patients with chronic CSC who had received half‑dose verteporfin PDT (3 mg/m2) was performed. The main outcome measures were resolution of subretinal fluid and best corrected visual acuity (BCVA).Results: Fifty‑three eyes of 51 patients with mean age of 45.01 ± 8.9 years were studied. Three, 6 and 12 months after half‑ose PDT, subretinal fluid was completely resolved in 51 eyes (96.2%). In 2 eyes (one patient), subretinal fluid decreased at 3 months but one year later, an increase in subretinal fluid was detected on OPTICAL COHERENCE TOMOGRAPHY (OCT) which completely resolved following additional PDT.Another patient with recurrence of subretinal fluid rejected further treatment. Mean baseline central subfield thickness was 385 ± 113.0µm which was decreased to 235 ± 39.7, 247 ± 49.7, and 244 ± 49.52 µm after 3, 6 and 12 months, respectively (allP -values<0.001). Mean BCVA was 0.33 ± 0.27 Log MAR before PDT and 0.11 ± 0.18, 0.11 ± 0.17, 0.17 ± 0.26 and 0.10 ± 0.23 Log MAR, 3, 6 and 12 months and at final visit (up to 60 months) after PDT, respectively (allP -values<0.001). Improvement ≥2 lines in BCVA occurred in 20 eyes (37.7%). Statistically significant correlations were found between improvement in BCVA and baseline BCVA, baseline central subfield thickness and central subfield thickness after resorption of subretinal fluid (P< 0.001, P=0.04 and P=0.01, respectively). No complications attributed to PDT were observed.Conclusion: Half‑dose PDT is effective for treatment of patients with chronic CSC.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    NASERIPOUR, MASOOD, GHASEMI FALAVARJANI, KHALIL, SEDAGHAT, AHAD, KARIMI MOGHADDAM, AREZOO, NASSERISINA, SADAF, & ALEMZADEH, SAYYED AMIRPOOYA. (2016). HALF?DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. JOURNAL OF OPHTHALMIC AND VISION RESEARCH, 11(1), 66-69. SID. https://sid.ir/paper/311625/en

    Vancouver: Copy

    NASERIPOUR MASOOD, GHASEMI FALAVARJANI KHALIL, SEDAGHAT AHAD, KARIMI MOGHADDAM AREZOO, NASSERISINA SADAF, ALEMZADEH SAYYED AMIRPOOYA. HALF?DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. JOURNAL OF OPHTHALMIC AND VISION RESEARCH[Internet]. 2016;11(1):66-69. Available from: https://sid.ir/paper/311625/en

    IEEE: Copy

    MASOOD NASERIPOUR, KHALIL GHASEMI FALAVARJANI, AHAD SEDAGHAT, AREZOO KARIMI MOGHADDAM, SADAF NASSERISINA, and SAYYED AMIRPOOYA ALEMZADEH, “HALF?DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY,” JOURNAL OF OPHTHALMIC AND VISION RESEARCH, vol. 11, no. 1, pp. 66–69, 2016, [Online]. Available: https://sid.ir/paper/311625/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button